Immunomedics (IMMU)

18.14 +0.28 (1.57%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (2/8/19 *Est.)

Latest Headlines

Form 8-K IMMUNOMEDICS INC For: Dec 14 December 17, 2018 5:02 PM - SEC Filing Form CT ORDER IMMUNOMEDICS INC December 6, 2018 4:34 PM - SEC Filing UPDATE: Immunomedics (IMMU) Announces Clinical Updates on Breast Cancer Programs With Sacituzumab Govitecan December 6, 2018 8:14 AM - StreetInsider Immunomedics Provides Clinical Updates on Breast Cancer Programs With Sacituzumab Govitecan December 6, 2018 8:04 AM - StreetInsider Immunomedics Provides Clinical Updates on Breast Cancer Programs With Sacituzumab Govitecan December 6, 2018 8:02 AM - Globe NewsWire Form 10-K/A IMMUNOMEDICS INC For: Jun 30 December 6, 2018 6:12 AM - SEC Filing New Research Coverage Highlights Immunomedics, Surmodics, PDF Solutions, Stepan, Express Scripts Holding, and BioCryst Pharmaceuticals — Consolidated Revenues, Company Growth, and Expectations for 2 November 27, 2018 8:55 AM - Globe NewsWire Form CT ORDER IMMUNOMEDICS INC November 19, 2018 11:53 AM - SEC Filing Put Buying Activity Continues in Immunomedics (IMMU), Targeting Jan. 18th PDUFA Date as Potential Downside Catalyst -Susquehanna November 13, 2018 1:48 PM - StreetInsider Immunomedics Announces Presentation at Upcoming Healthcare Conferences November 8, 2018 8:00 AM - Globe NewsWire Immunomedics Announces Presentation at Upcoming Healthcare Conferences November 8, 2018 8:00 AM - StreetInsider Immunomedics (IMMU) Reports Q1 Loss of $0.34 November 7, 2018 5:05 PM - StreetInsider Form 10-Q IMMUNOMEDICS INC For: Sep 30 November 7, 2018 4:19 PM - SEC Filing Form 8-K IMMUNOMEDICS INC For: Nov 07 November 7, 2018 4:09 PM - SEC Filing Immunomedics Announces First Quarter Fiscal 2019 Results and Provides Corporate Update November 7, 2018 4:05 PM - Globe NewsWire Immunomedics Announces First Quarter Fiscal 2019 Results and Provides Corporate Update November 7, 2018 4:05 PM - StreetInsider Immunomedics Expands Clinical Collaboration With Astrazeneca to Include Metastatic Non-Small Cell Lung Cancer November 7, 2018 4:00 PM - Globe NewsWire Immunomedics Expands Clinical Collaboration With Astrazeneca to Include Metastatic Non-Small Cell Lung Cancer November 7, 2018 4:00 PM - StreetInsider Morgan Stanley Starts Immunomedics (IMMU) at Overweight November 5, 2018 3:49 AM - StreetInsider Immunomedics to Report First Quarter Fiscal 2019 Results and Host Conference Call and Webcast on November 7, 2018 October 31, 2018 8:00 AM - Globe NewsWire Immunomedics to Report First Quarter Fiscal 2019 Results and Host Conference Call and Webcast on November 7, 2018 October 31, 2018 8:00 AM - StreetInsider Form 10-K/A IMMUNOMEDICS INC For: Jun 30 October 29, 2018 4:09 PM - SEC Filing Piper Jaffray Starts Immunomedics (IMMU) at Overweight October 18, 2018 4:05 PM - StreetInsider Detailed Research: Economic Perspectives on Graco, Immunomedics, Concert Pharmaceuticals, Macquarie Infrastructure, Systemax, and Service Corporation International — What Drives Growth in Today&apos October 12, 2018 9:15 AM - Globe NewsWire Form 8-K IMMUNOMEDICS INC For: Oct 02 October 3, 2018 8:16 AM - SEC Filing Form 8-K IMMUNOMEDICS INC For: Sep 24 September 28, 2018 4:33 PM - SEC Filing Form 3 IMMUNOMEDICS INC For: Sep 24 Filed by: Andrews Kurt J. September 27, 2018 4:33 PM - SEC Filing Form 4 IMMUNOMEDICS INC For: Sep 24 Filed by: Freedberg Jared September 26, 2018 5:03 PM - SEC Filing Form 3 IMMUNOMEDICS INC For: Sep 24 Filed by: Freedberg Jared September 26, 2018 5:00 PM - SEC Filing Form 4 IMMUNOMEDICS INC For: Apr 02 Filed by: Islam Khalid September 19, 2018 3:22 PM - SEC Filing Full Article List